GH therapy is the only approved pharmacotherapy for PWS to date, with proven efficacy to normalize linear growth, significantly improve body composition and body mass index, and modify the natural history of PWS with a good safety profile [9]. This evidence concerns the gene GH1 and Prader-Willi syndrome.